Search research articles
Contact Us
Filters
Showing results (171-180 of 186) with videos related to
Page
of 19
Sort By:
European Urology
|
January 1, 1992
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia
H O Beisland, B Binkowitz, E Brekkan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer
H Matsuyama, Y Pan, K Oba, et al.
Urologic Oncology
|
January 14, 2011
Standardization in pathologic assessment of transitional cell cancer of the bladder
M J Droller, P Ekman, K Gohji, et al.
Emotion (Washington, D.C.)
|
August 6, 2003
Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease
E L Rosenberg, P Ekman, W Jiang, et al.
Urology
|
April 1, 1997
How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
J Altwein, P Ekman, M Barry, et al.
Aktuelle Urologie
|
October 21, 2003
The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer
H Matsuyama, Y Pan, K Oba, et al.
British Journal of Urology
|
July 1, 1997
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study
J Ramon, T H Lynch, I Eardley, et al.
Oncogene
|
March 4, 1998
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
C Li, C Larsson, A Futreal, et al.
Arthritis and Rheumatism
|
January 27, 1999
Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid
S Nikkari, K Rantakokko, P Ekman, et al.
Laeknabladid
|
January 13, 2010
[Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study.]
G V Einarsson, J T Andersen, T Gislason, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 186) with videos related to
Sort By:
Page
of 19
European Urology
|
January 1, 1992
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia
H O Beisland, B Binkowitz, E Brekkan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer
H Matsuyama, Y Pan, K Oba, et al.
Urologic Oncology
|
January 14, 2011
Standardization in pathologic assessment of transitional cell cancer of the bladder
M J Droller, P Ekman, K Gohji, et al.
Emotion (Washington, D.C.)
|
August 6, 2003
Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease
E L Rosenberg, P Ekman, W Jiang, et al.
Urology
|
April 1, 1997
How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
J Altwein, P Ekman, M Barry, et al.
Aktuelle Urologie
|
October 21, 2003
The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer
H Matsuyama, Y Pan, K Oba, et al.
British Journal of Urology
|
July 1, 1997
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study
J Ramon, T H Lynch, I Eardley, et al.
Oncogene
|
March 4, 1998
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
C Li, C Larsson, A Futreal, et al.
Arthritis and Rheumatism
|
January 27, 1999
Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid
S Nikkari, K Rantakokko, P Ekman, et al.
Laeknabladid
|
January 13, 2010
[Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study.]
G V Einarsson, J T Andersen, T Gislason, et al.
Page
of 19